TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LENZ

LENZ Therapeutics Inc

Healthcare · Biotechnology

4.10$ +1.2% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LENZ
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 93.5% 99.9% 99.3% 95.5% 98.4% 98.5%
100.0% 87.8% 99.8% 94.7% 49.9% 9.4% 8.2%
100.0% 87.8% 99.8% 94.7% 93.5% 97.1% 95.6%
0.0% 0.8%
0.0% 1.0%
37,066.7% 143.4% 177.5% 151.5% 231.7% 5.2% 7.0%
37,066.7% 142.0% 6.8% 20.2% 26.3% 4.8% 6.9%
36,750.0% 0.2% 0.2% 0.3% 0.2%
2.8% 2.5% 10.1% 8.1% 2.0% 1.4%
-36,966.7% -43.4% -77.5% -51.5% -131.7% 94.8% 93.0%
-36,966.7% -312.8% -78.9% -53.8% -135.3% -67.4% -74.3%
138,283.3% 36.8% 45.2% 16.7% 11.6% 9.9% 9.4%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?